Nicolás Cuenca Selected Research

Norgestrel (DL-Norgestrel)

1/2019	Norgestrel, a Progesterone Analogue, Promotes Significant Long-Term Neuroprotection of Cone Photoreceptors in a Mouse Model of Retinal Disease.
1/2016	Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolás Cuenca Research Topics

Disease

24	Retinitis Pigmentosa (Pigmentary Retinopathy) 03/2022 - 12/2010
20	Retinal Degeneration 03/2022 - 09/2005
11	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 09/2010
7	Inflammation (Inflammations) 05/2022 - 09/2016
7	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2005
7	Ganglion Cysts (Ganglion) 02/2020 - 07/2013
4	Disease Progression 01/2022 - 01/2018
4	Glaucoma 01/2022 - 11/2014
4	Gliosis 10/2021 - 11/2012
4	Parkinsonian Disorders (Parkinsonism) 01/2018 - 10/2011
3	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2022 - 11/2014
3	Retinal Diseases 01/2020 - 01/2018
2	Macular Degeneration (Age-Related Maculopathy) 11/2021 - 11/2014
2	Blindness (Hysterical Blindness) 01/2021 - 02/2020
2	Synucleinopathies 01/2018 - 06/2014
2	Dementia (Dementias) 01/2018 - 06/2014
2	Infections 01/2018 - 09/2016
2	Wounds and Injuries (Trauma) 09/2016 - 11/2014
2	Dyskinesias (Dyskinesia) 03/2012 - 10/2011
1	Ischemia 03/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	Microaneurysm 12/2021
1	Vascular Diseases (Vascular Disease) 12/2021
1	Photophobia (Light Sensitivity) 06/2021
1	Dysbiosis 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2020
1	Eye Diseases (Eye Disease) 08/2020
1	Atrophy 06/2019
1	Chronobiology Disorders (Circadian Rhythm Disorder) 06/2019
1	Retinal Dystrophies 01/2018
1	Vision Disorders (Hemeralopia) 01/2018
1	Brain Diseases (Brain Disorder) 01/2018
1	Lewy Body Disease (Lewy Body Dementia) 01/2018
1	Colitis 09/2016
1	Neuroinflammatory Diseases 01/2016
1	3 Progressive Supranuclear Palsy 06/2014
1	Alzheimer Disease (Alzheimer's Disease) 06/2014
1	Invasive Candidiasis 05/2014
1	Mycoses (Diseases, Fungus) 05/2014

Drug/Important Bio-Agent (IBA)

27	Retinaldehyde (Retinal)IBA 03/2022 - 09/2005
6	melanopsinIBA 06/2019 - 07/2013
5	Neuroprotective AgentsIBA 01/2022 - 07/2011
4	ursodoxicoltaurineIBA 01/2022 - 07/2011
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	SynucleinsIBA 01/2019 - 06/2014
3	Rhodopsin (Visual Purple)IBA 01/2017 - 12/2010
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 03/2022 - 08/2020
2	N-Methylaspartate (NMDA)IBA 03/2022 - 02/2020
2	LipopolysaccharidesIBA 03/2022 - 01/2018
2	MelatoninIBA 11/2021 - 03/2011
2	Norgestrel (DL-Norgestrel)FDA LinkGeneric 01/2019 - 01/2016
2	CannabinoidsIBA 01/2019 - 03/2014
2	Progesterone FDA LinkGeneric 01/2019 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2015
2	safranalIBA 07/2015 - 01/2012
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2013 - 12/2005
2	NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA 03/2012 - 10/2011
2	RotenoneIBA 03/2012 - 10/2011
2	NAD (NADH)IBA 03/2012 - 10/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022
1	sodium iodateIBA 03/2022
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 03/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	AcidsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Kainic Acid (Kainate)IBA 02/2020
1	ITH12674IBA 02/2020
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2019
1	Metal-Organic FrameworksIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Oxygen (Dioxygen)IBA 01/2018
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2016
1	c-Mer Tyrosine KinaseIBA 08/2015
1	Connexin 43 (Connexin43)IBA 01/2015
1	Blood Glucose (Blood Sugar)IBA 11/2014
1	Therapeutic UsesIBA 10/2014
1	Serine (L-Serine)FDA Link 06/2014
1	AntibodiesIBA 05/2014
1	Cannabinoid Receptor AgonistsIBA 03/2014
1	HU 211 (HU 210)IBA 03/2014
1	ProinsulinIBA 12/2012
1	Glial Fibrillary Acidic ProteinIBA 11/2012
1	PesticidesIBA 10/2011
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 09/2010
1	alpha-SynucleinIBA 06/2007
1	Proteins (Proteins, Gene)FDA Link 06/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2012
1	Microspheres (Microsphere) 01/2017
1	Cell Transplantation 11/2014
1	Transplantation 10/2013